Navigation Links
Two Pharmaceutical Firms Select Clinipace to Deploy New Grant Management Solution
Date:2/18/2009

TEMPO™ for Grant Management assists medical affairs departments in deploying comprehensive investigator-initiated research grant management program

Morrisville, N.C. (PRWEB) February 18, 2009 -- Clinipace, a growing clinical research solutions company, today announced that it has been selected by two pharmaceutical firms to deploy its TEMPO™ for Grant Management solution.

Life science firms are highly cognizant of the multiple pressures to be transparent and compliant in their funding of investigator initiated research (IIR), and are turning to Clinipace in increasing numbers to help them better manage this process. Funding this research is a strategic investment, and maximizing return is critical whether in the form of publications, useful data or stronger community relationships.

Funding investigator-initiated research, in the form of grants, has become an important part of the overall clinical development program, for drugs and devices. This research furthers scientific understanding of real-world clinical profile and product utilization, identifies new indications, and augments the medical literature. As a result, medical affairs departments in many life science companies have established centralized IIR grant management functions and processes.

"Clinipace offers the only software management system that enables life science firms to centralize the application and evaluation process across the portfolio, while simultaneously empowering investigators with the tools and know-how to support individual research projects, all within one software platform. This ensures visibility and success for all stakeholders," said Jeff Williams, Chief Executive Officer at Clinipace.


Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist
2. Frost & Sullivan: Australian Pharmaceuticals and Life Sciences IT Market Is Still Growing
3. Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2009 Financial Results
4. National Pharmaceutical Council on Economic Stimulus Package: Comparative Effectiveness Research Funding Should Target Improvements in Quality of Patient Care
5. Cadence Pharmaceuticals to Raise $86.6 Million in a Private Placement of Common Stock
6. Angiotech Pharmaceuticals, Inc. - Notice of conference call and webcast
7. Tracon Pharmaceuticals to Present Clinical Stage Programs at AACR 2009
8. Combination Products Executive Forum to be Hosted by CHI's Pharmaceutical Strategy Series
9. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results Teleconference and Webcast
10. Union Springs Pharmaceuticals Introduces New, More Effective Respirator
11. Shengtai Pharmaceutical Schedules 2009 Second Quarter Financial Results and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 26, 2015 On June 4, 2015, ... live online broadcast at 6:00pm PST/9:00 pm EST. ... Master™ Alice Branton welcomes the public to attend and ... of profound knowledge, transformation and enlightenment. The webinar ... no previous knowledge, experience or other prerequisites are required. ...
(Date:5/26/2015)... Writers and editors can use the ... to make creating, editing, and managing content a ... management system (CCMS) software provider, certified that their ... Editor Version 17.0, Syncro Soft’s latest software update. ... key editorial functionality of the Vasont CCMS into ...
(Date:5/26/2015)... Glendale, CA (PRWEB) May 26, 2015 ... joined forces with MarkLogic Corporation. The alliance ensures ... NoSQL database platform and General Networks’ expertise in ... General Networks and MarkLogic will help customers integrate, ... improve decision-making and business processes. , “Our customers ...
(Date:5/26/2015)... DC (PRWEB) May 26, 2015 ... podiatrist Dr. Enzo J. Leone (Pasadena and ... service as the Maryland Podiatric Medical Association (MPMA) President ... , Dr. Leone received his Doctorate in Podiatric Medicine ... at the West Jersey Hospital in Voorhees, New Jersey. ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 U.S. Food ... in the United States are extensive and can be ... firm that helps medical device companies comply with FDA ... medical device companies navigate FDA requirements. , 1. ... the United States can be a lengthy process depending ...
Breaking Medicine News(10 mins):Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 3Health News:Vasont Systems Certifies the Integration between the Vasont® Component Content Management System and oXygen® XML Editor 17.0 2Health News:General Networks Corporation Announces Alliance with MarkLogic 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives MPMA Service Award 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 3Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 4
... ever-growing menace on the Internet. Now a millennium ... health related web-sites that are such havens of ... guideline for surfers to be weary of tall ... can be accessed on http://www.ratbags.com/rsoles/categories.htm, ,Statutary Warning: ...
... in Russia have reported to have said that more than ... every second newborn discharged from a maternity clinic is suffering ... from 45.3 percent in 1992 to just 30 percent last ... Russia's Academy of Medical Science. She thinks that the decline ...
... predict overall long-term survival rates in both men and women. ... , ,Researchers studied survival rates based on a lung ... performed the lung function test on a group of more ... in age from 20 to 89 years at enrollment. They ...
... Transdermal hormone replacement therapy (HRT) does not ... postmenopausal women with existing ,coronary artery disease ... ,Atherosclerosis Study), researchers randomized 255 ,postmenopausal women ... receive either transdermal HRT--17-beta-estradiol ,with or without ...
... in the membranes of red ,blood cells infected by ... Plasmodium falciparum, apparently uses these holes to supply itself ... , ,The discovery may lead to the development ... disease. ,Malaria kills more than one million people each ...
... ability to regulate ,their blood sugar by adding a little ... recognize and respond to insulin, the hormone that removes excess ... a test tube and in animal studies, the spice appeared ... is too soon to recommend the spice as a regular ...
Cached Medicine News:Health News:Feeding channel created by malaria parasite - a new target for ,malaria treatments 2
(Date:5/26/2015)... 26, 2015 ViiV Healthcare, Aurobindo ... announced today that Aurobindo Pharma has submitted an Abbreviated ... Approval, to the Food and Drug Administration (FDA), for ... for a generic version of dolutegravir, less than two ... in the United States . ...
(Date:5/26/2015)...  Respiratory Motion, Inc. – Research being presented ... the Japanese Society of Anesthesiologists shows that commonly ... miss critical early indicators of impending deterioration and ... that respiratory volume monitoring using the ExSpiron™ Patient ... patients than traditional capnography and pulse oximetry technologies ...
(Date:5/26/2015)... 2015 Helping seniors stay as independent ... be a full-time job for families and caregivers. ... gap when they can,t be with their aging ... eHeart Health Monitoring, LLC , not all personal ... Photo - ...
Breaking Medicine Technology:ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 2Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 3Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 5eHeart Health Monitoring Gives Tips on Choosing the Right Personal Alert System for Aging Loved Ones 2eHeart Health Monitoring Gives Tips on Choosing the Right Personal Alert System for Aging Loved Ones 3eHeart Health Monitoring Gives Tips on Choosing the Right Personal Alert System for Aging Loved Ones 4
... 4, 2010 Poniard Pharmaceuticals, Inc. (Nasdaq: ... therapies, today announced that it has been awarded $244,479 ... Qualifying Therapeutic Discovery Project (QTDP) program established under Section ... use the grant to advance the development of its ...
... Nov. 4, 2010 Eli Lilly and Company (NYSE: ... Officer John Lechleiter Ph.D. today presented an $11.6 million ... contributions of Lilly,s U.S. employees and retirees and a ... were raised for the Central Indiana chapter and other ...
Cached Medicine Technology:Poniard Pharmaceuticals Awarded $244,479 Grant Under Qualifying Therapeutic Discovery Project Program 2Poniard Pharmaceuticals Awarded $244,479 Grant Under Qualifying Therapeutic Discovery Project Program 3Lilly Surpasses United Way 2010 Campaign Goal 2
Only SurLok combines precise control, enhanced basket and grasper strength, and the added security of a unique wire-locking mechanism. You can feel the difference. The SurLok flat-wire and grasper ha...
The SurLok helical stone baskets are constructed of strong and resilient stainless steel. These helical baskets present a spiral profile that effectively clears both stones and fragments....
... The 3-way design permits ... irrigation lumen in the Foley ... in Latex construction, as well ... a wide variety of models ...
... facilitates negotiation of the prostatic urethra. ... length olive Coude tip with a ... construction provides added stiffness and radiopacity. ... a variety of materials, eye configurations, ...
Medicine Products: